Virax Biolabs Group Ltd Adjustments For Decrease Increase In Trade Account Receivable
Virax Biolabs Group Ltd (VRAX) reported Adjustments For Decrease Increase In Trade Account Receivable of $337.58 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable · last filed 2025-07-02
| Period end | Adjustments For Decrease Increase In Trade Account Receivable 12 month |
|---|---|
| 2025-03-31 | $337.58K 20-F · filed 2025-07-02 |
| 2022-03-31 | $928.00 20-F · filed 2024-08-20 |
| 2021-03-31 | -$928.00 20-F · filed 2022-08-12 |